Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Tradewind BioScience General Information
Developing antibody therapeutics that attack primary cancer and inhibit metastatic development, particularly promising for late-stage cancer patients[3][6]
Contact Information
Website
Primary Industry
Biotech
Corporate Office
San Carlos, California
United States
United States
Drug Pipeline
Pre-clinical
Key Partnerships
University of Michigan (IP licensing)[6]
Tradewind BioScience Funding
No funding data available
To view Tradewind BioScience's complete valuation and funding history, request access »